Cancer-cell-derived EVs contain potent proangiogenic factors such as IL-6 and vascular endothelial growth factor (VEGF), along with other molecules capable of enhancing endothelial cell invasion and organization into tubule-like structures. Here, VEGFA is linked to cancer.